⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5933682 | 0.84 | TDP1 (0.39) | — | |
| SCHEMBL5018097 | 0.69 | TDP1 (0.54) | — | |
| SCHEMBL22843645 | 0.62 | — | — | |
| SCHEMBL81105 | 0.61 | — | — | |
| SCHEMBL598898 | 0.61 | ALDH1A1 (0.50) | — | |
| SCHEMBL19531760 | 0.57 | TDP1 (0.47) | — | |
| SCHEMBL19226305 | 0.57 | ALDH1A1 (0.44) | — | |
| SCHEMBL8055318 | 0.57 | — | — | |
| Ammonia Solution, Strong SCHEMBL5183336 | 0.57 | — | — | |
| SCHEMBL2606455 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352350-B2 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210323952-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2021-10-21 | — | — | US | disclosed |